FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16179011000001105: FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Dec 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57120201000001118 FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
57120301000001110 FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Is a Estradiol 50micrograms/24hours transdermal patches true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Is a Estradiol 50micrograms patch false Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has active ingredient Estradiol true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has specific active ingredient Estradiol true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Is a FemSeven Sequi Phase 1 true Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Is a Estradiol 50micrograms/24hours transdermal patches false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) 2 patch Has AMP True FemSeven Sequi 50micrograms/24hours Phase 1 patches (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start